Efficacy and safety of acupuncture combined with Chinese herbal medicine in the treatment of primary liver cancer A protocol for systematic review and meta-analysis

被引：4
作者：
Dong, Shen [1 ]
Zhuang, Xiong [1 ,2 ]
Yangyang, Liu [1 ,3 ]
Yan, Leng [1 ,2 ]
Houbo, Deng [1 ,2 ]
Song, Wang [1 ]
Meng, Xiangtong [1 ]
Tiejun, Liu [1 ,2 ]
机构：
[1] Changchun Univ Chinese Med, 1035 Bo Shuo Rd, Changchun, Jilin, Peoples R China
[2] Changchun Univ Chinese Med, Affiliated Hosp 1, Dept Hepatol, 1478 Gongnong Rd, Changchun, Jilin, Peoples R China
[3] Changchun Univ Chinese Med, Affiliated Hosp 1, Endocrinol, 1478 Gongnong Rd, Changchun, Jilin, Peoples R China
来源：
MEDICINE | 2021年 / 100卷 / 40期
基金：
中国国家自然科学基金;
关键词：
acupuncture; Chinese herbal medicine; efficacy; meta-analysis; primary liver cancer; protocol; systematic review;
D O I：
10.1097/MD.0000000000027497
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: Primary liver cancer (PLC) is a common cancer, and its morbidity and mortality are ranked 6th and 3rd in the world for malignant tumors, respectively. And this number is still on the rise, seriously endangering people's health. In recent years, acupuncture combined with Chinese herbal medicine have been widely used in the treatment of PLC, and there are few restrictions. However, we have not found a meta-analysis of their synergistic effects. Therefore, this systematic review and meta-analysis will evaluate the efficacy and acupuncture combined with Chinese herbal medicine in the treatment of primary liver cancer. Method: We will search the following databases from inception up to August 20, 2021: PubMed, Web of Science, Embase, AMED, Cochrane Library, CNKI, VIP, CBM, and Wanfang. There will be no restrictions regarding publication date or language. We will apply a combination of medical keywords and words, including "acupuncture," "Chinese herbal medicine" and "primary liver cancer". Additionally, we will manually search all reference lists from relevant systematic reviews to find other eligible studies. We will use the random effects model in REVMAN v5.3 for meta-analysis. The study for acupuncture combined with Chinese herbal medicine in the treatment of PLC was a randomized controlled study. Two researchers will independently review the research selection, data extraction, and research quality assessments. Finally, we will observe the outcome measures. Results: This study will provide evidence-based medical evidence for the treatment of PLC with a combination of acupuncture and Chinese herbal medicine, and provide new ideas and methods for the treatment of PLC. Registration number: INPLASY202180103
引用
收藏
页数：4
相关论文
共 13 条
[1]   Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JS']JSMO, KSMO, MOS and SSO [J].
Chen, L-T ;
Martinelli, E. ;
Cheng, A-L ;
Pentheroudakis, G. ;
Qin, S. ;
Bhattacharyya, G. S. ;
Ikeda, M. ;
Lim, H-Y ;
Ho, G. F. ;
Choo, S. P. ;
Ren, Z. ;
Malhotra, H. ;
Ueno, M. ;
Ryoo, B-Y ;
Kiang, T. C. ;
Tai, D. ;
Vogel, A. ;
Cervantes, A. ;
Lu, S-N ;
Yen, C-J ;
Huang, Y-H ;
Chen, S-C ;
Hsu, C. ;
Shen, Y-C ;
Tabernero, J. ;
Yen, Y. ;
Hsu, C-H ;
Yoshino, T. ;
Douillard, J-Y .
ANNALS OF ONCOLOGY, 2020, 31 (03) :334-351
[2]   Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity [J].
Herlihy, David R. B. ;
Thomas, Matthew ;
Tran, Quoc H. ;
Puttaswamy, Vikram .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (07)
[3]  
International Agency for Research on Cancer World Health Organization, LIVESOURCE GLOB 2020
[4]   Management of Hepatocellular Carcinoma in Japan: JS']JSH Consensus Statements and Recommendations 2021 Update [J].
Kudo, Masatoshi ;
Kawamura, Yusuke ;
Hasegawa, Kiyoshi ;
Tateishi, Ryosuke ;
Kariyama, Kazuya ;
Shiina, Shuichiro ;
Toyoda, Hidenori ;
Imai, Yasuharu ;
Hiraoka, Atsushi ;
Ikeda, Masafumi ;
Izumi, Namiki ;
Moriguchi, Michihisa ;
Ogasawara, Sadahisa ;
Minami, Yasunori ;
Ueshima, Kazuomi ;
Murakami, Takamichi ;
Miyayama, Shiro ;
Nakashima, Osamu ;
Yano, Hirohisa ;
Sakamoto, Michiie ;
Hatano, Etsuro ;
Shimada, Mitsuo ;
Kokudo, Norihiro ;
Mochida, Satoshi ;
Takehara, Tetsuo .
LIVER CANCER, 2021, 10 (03) :181-223
[5]   Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future [J].
Liao, Xia ;
Bu, Yang ;
Jia, Qingan .
GENES & DISEASES, 2020, 7 (03) :370-379
[6]   Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine [J].
Ling, Chang-quan ;
Fan, Jia ;
Lin, Hong-sheng ;
Shen, Feng ;
Xu, Zhen-ye ;
Lin, Li-zhu ;
Qin, Shu-kui ;
Zhou, Wei-ping ;
Zhai, Xiao-feng ;
Li, Bai ;
Zhou, Qing-hui .
JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2018, 16 (04) :236-248
[7]   Traditional Chinese Medicine in Cancer Care: A Review of Case Reports Published in Chinese Literature [J].
Liu, Jianping ;
Li, Xun ;
Liu, Jingyuan ;
Ma, Lixin ;
Li, Xinxue ;
Fonnebo, Vinjar .
FORSCHENDE KOMPLEMENTARMEDIZIN, 2011, 18 (05) :257-263
[8]  
Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.i4086, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.b2700, 10.1136/bmj.b2535, 10.1016/j.ijsu.2010.07.299]
[9]  
Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n160, 10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]
[10]  
SHEN H, 2021, EUR J PHARMACOL
12